Evidence map›Paper›PMID 31779692›Full record

ArticleArthritis research & therapy2019

Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain.

Marika Cordaro, Rosalba Siracusa, Daniela Impellizzeri, Ramona D' Amico, Alessio Filippo Peritore, Rosalia Crupi, Enrico Gugliandolo, Roberta Fusco, Rosanna Di Paola, Carlo Schievano and 1 more

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Role of microglia in diabetic neuropathic pain.Frontiers in cell and developmental biology · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Antioxidants (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Key Mechanisms and Potential Implications ofAntioxidants (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 3 countries.

Marika CordaroDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy.
Rosalba SiracusaDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy.
Daniela ImpellizzeriDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy.
Ramona D' AmicoDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy.
Alessio Filippo PeritoreDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy.
Rosalia CrupiDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy.
Enrico GugliandoloDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy.
Roberta FuscoDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy.
Rosanna Di PaolaDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy.
Carlo SchievanoInnovative Statistical Research srl, Prato Della Valle 24, I-35123, Padova, Italy.
Salvatore CuzzocreaDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy. salvator@unime.it.ORCID 0000-0001-6131-3690
University of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteoarthritis is increasingly recognized as the result of a complex interplay between inflammation, chrondrodegeneration, and pain. Joint mast cells are considered to play a key role in orchestrating this detrimental triad. ALIAmides down-modulate mast cells and more generally hyperactive cells. Here we investigated the safety and effectiveness of the ALIAmide N-palmitoyl-D-glucosamine (PGA) in inflammation and osteoarthritis pain.

methodsAcute toxicity of micronized PGA (m-PGA) was assessed in rats following OECD Guideline No.425. PGA and m-PGA (30 mg/kg and 100 mg/kg) were orally administered to carrageenan (CAR)-injected rats. Dexamethasone 0.1 mg/kg was used as reference. Paw edema and thermal hyperalgesia were measured up to 6 h post-injection, when also myeloperoxidase activity and histological inflammation score were assessed. Rats subjected to intra-articular injection of sodium monoiodoacetate (MIA) were treated three times per week for 21 days with PGA or m-PGA (30 mg/kg). Mechanical allodynia and motor function were evaluated at different post-injection time points. Joint histological and radiographic damage was scored, articular mast cells were counted, and macrophages were immunohistochemically investigated. Levels of TNF-α, IL-1β, NGF, and MMP-1, MMP-3, and MMP-9 were measured in serum using commercial colorimetric ELISA kits. One- or two-way ANOVA followed by a Bonferroni post hoc test for multiple comparisons was used.

resultsAcute oral toxicity of m-PGA resulted in LD50 values in excess of 2000 mg/kg. A single oral administration of PGA and m-PGA significantly reduced CAR-induced inflammatory signs (edema, inflammatory infiltrate, and hyperalgesia), and m-PGA also reduced the histological score. Micronized PGA resulted in a superior activity to PGA on MIA-induced mechanical allodynia, locomotor disability, and histologic and radiographic damage. The MIA-induced increase in mast cell count and serum level of the investigated markers was also counteracted by PGA and to a significantly greater extent by m-PGA.

conclusionsThe results of the present study showed that PGA is endorsed with anti-inflammatory, pain-relieving, and joint-protective effects. Moreover, it proved that particle size reduction greatly enhances the activity of PGA, particularly on joint pain and disability. Given these results, m-PGA could be considered a valuable option in the management of osteoarthritis.

Indexed as

AnalgesicsAnimalsCarrageenanFemaleGlucosamineHyperalgesiaInflammationIodoacetic AcidMaleMast CellsMatrix Metalloproteinase 1OsteoarthritisPainPain MeasurementParticle SizeRats, Sprague-DawleyAnalgesicsCarrageenanGlucosamineIodoacetic AcidMatrix Metalloproteinase 1Tumor Necrosis Factor-alphaALIAmidesMast cellsMicronizationN-palmitoyl-D-glucosamineOsteoarthritisPainPalmitoylethanolamide

Identifiers

PMID31779692
PMCPMC6883534
OpenAlexW2990667221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.